Guidance in topic selection

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Technology type

Technology type

Topic selection decision

Topic selection decision

Type 1 selected

Type

Showing 1 to 6 of 6

TitleTechnology typeDecisionDecision date
Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis TS ID 11895MedicineNot selected
Dimethyl fumarate for treating relapsing-remitting multiple sclerosis in people aged 13 to 17 TS ID 11778MedicineNot selected
Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020]MedicineNot selected
Glatiramer acetate depot for multiple sclerosis [TS ID 10620]MedicineFurther information required
Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]MedicineNot selected
Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosisProcedureFurther information required

Results per page

  1. 10
  2. 25
  3. 50
  4. All